GH Research Statistics
Total Valuation
GH Research has a market cap or net worth of $2.03 billion. The enterprise value is $1.66 billion.
| Market Cap | 2.03B |
| Enterprise Value | 1.66B |
Important Dates
The last earnings date was Thursday, August 6, 2026, before market open.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
GH Research has 68.61 million shares outstanding. The number of shares has increased by 12.02% in one year.
| Current Share Class | 68.61M |
| Shares Outstanding | 68.61M |
| Shares Change (YoY) | +12.02% |
| Shares Change (QoQ) | +6.15% |
| Owned by Insiders (%) | 24.47% |
| Owned by Institutions (%) | 36.94% |
| Float | 29.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 5.54 |
| P/TBV Ratio | 5.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 28.70, with a Debt / Equity ratio of 0.00.
| Current Ratio | 28.70 |
| Quick Ratio | 28.22 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -257.14 |
Financial Efficiency
Return on equity (ROE) is -18.79% and return on invested capital (ROIC) is -13.45%.
| Return on Equity (ROE) | -18.79% |
| Return on Assets (ROA) | -13.02% |
| Return on Invested Capital (ROIC) | -13.45% |
| Return on Capital Employed (ROCE) | -19.89% |
| Weighted Average Cost of Capital (WACC) | 11.35% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$853,014 |
| Employee Count | 73 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +137.95% in the last 52 weeks. The beta is 1.29, so GH Research's price volatility has been higher than the market average.
| Beta (5Y) | 1.29 |
| 52-Week Price Change | +137.95% |
| 50-Day Moving Average | 25.79 |
| 200-Day Moving Average | 18.41 |
| Relative Strength Index (RSI) | 60.55 |
| Average Volume (20 Days) | 329,992 |
Short Selling Information
The latest short interest is 1.95 million, so 2.84% of the outstanding shares have been sold short.
| Short Interest | 1.95M |
| Short Previous Month | 1.94M |
| Short % of Shares Out | 2.84% |
| Short % of Float | 6.61% |
| Short Ratio (days to cover) | 8.13 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -71.43M |
| Pretax Income | -62.27M |
| Net Income | -62.27M |
| EBITDA | -71.13M |
| EBIT | -71.49M |
| Earnings Per Share (EPS) | -$0.99 |
Balance Sheet
The company has $362.65 million in cash and $360,000 in debt, with a net cash position of $362.29 million or $5.28 per share.
| Cash & Cash Equivalents | 362.65M |
| Total Debt | 360,000 |
| Net Cash | 362.29M |
| Net Cash Per Share | $5.28 |
| Equity (Book Value) | 359.49M |
| Book Value Per Share | 5.46 |
| Working Capital | 355.97M |
Cash Flow
In the last 12 months, operating cash flow was -$45.65 million and capital expenditures -$180,000, giving a free cash flow of -$45.83 million.
| Operating Cash Flow | -45.65M |
| Capital Expenditures | -180,000 |
| Depreciation & Amortization | 101,000 |
| Net Borrowing | -267,000 |
| Free Cash Flow | -45.83M |
| FCF Per Share | -$0.67 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GH Research does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.02% |
| Shareholder Yield | -12.02% |
| Earnings Yield | -3.06% |
| FCF Yield | -2.25% |
Analyst Forecast
The average price target for GH Research is $42.89, which is 45.24% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $42.89 |
| Price Target Difference | 45.24% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |